Cell-Type-Specific Atf6Α Programs Regulate Epithelial Mitochondrial Homeostasis And Pericyte Remodeling During Physiological And Exposure-Accelerated Lung Aging

Aging Pathway
Therapeutic
The protein ATF6α plays a cell-type-specific role in regulating how lung cells maintain their energy-producing structures and how cells around blood vessels remodel during both natural and smoke-accelerated lung aging.
Author

Gemini

Published

July 21, 2026

As our bodies age, the delicate balance of protein production and breakdown, known as proteostasis, can falter, particularly in organs like the lungs. Scientists have been exploring the role of a cellular stress response system called the Unfolded Protein Response (UPR) in this process, especially in the context of lung aging and related diseases.

One key player in the UPR is a protein called ATF6α. Recent research has shed light on how a lack of ATF6α affects lung aging, both naturally and when accelerated by exposure to smoke. It was found that mice deficient in ATF6α experienced faster signs of lung aging, specifically a condition called alveolar simplification, which worsened with smoking.

Interestingly, while smoking typically causes scarring in the small airways, this particular pathology was not observed in the smoke-exposed mice lacking ATF6α. This suggests that ATF6α has different functions depending on the type of cell it’s in. For instance, in specialized lung cells called alveolar epithelial type 2 cells (AEC2s), which are vital for lung repair, ATF6α helps maintain the health and energy production of mitochondria, the cell’s powerhouses. It also supports these cells’ ability to transform into other essential lung cells.

Conversely, in cells surrounding blood vessels in the lung, known as pericytes, ATF6α was found to encourage their movement, their transformation into scar-forming cells, and the production of collagen, a key component of scar tissue. These discoveries highlight that ATF6α acts as a specific regulator for different cell programs during lung aging. This understanding is crucial for future therapeutic strategies, emphasizing the need to study ATF6α’s precise roles in various physiological and disease contexts before developing treatments that target this pathway.


Source: link to paper